Navidea biopharmaceuticals, inc. enters asset purchase agreement with meilleur technologies, inc. for rights to nav4694

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it has signed an asset purchase agreement allowing meilleur technologies, inc.
NAVB Ratings Summary
NAVB Quant Ranking